BIOMAT Database Logo BIOMAT Database Logo

Partial purification and characterization of immunoglobulin production stimulating factor derived from Namalwa cells. 1989

K Yamada, and K Akiyoshi, and H Murakami, and T Sugahara, and I Ikeda, and K Toyoda, and H Omura
Department of Food Science and Technology, Faculty of Agriculture, Kyushu University, Fukuoka, Japan.

We screened for immunoglobulin (Ig) production stimulating factor (IPSF) which enhanced Ig production of human-to-human hybridomas in serum-free culture, and found that culture supernatant and lysate of human lymphoblastoid Namalwa cells stimulated proliferation and Ig production of human-to-human hybridoma HB4C5 cells. The IPSF in Namalwa lysate was partially purified with DEAE-Toyopearl 650M, hydroxylapatite and Superose 6HR 10/30 column chromatographies. The partially purified IPSF was a macromolecule of about 500,000 dalton containing 72,000 dalton protein as a major component. The activity was stable at pH 6 to 12, but inactivated partially by heating over 40 degrees C (60% decrease) and completely by trypsin digestion. These results suggest that the IPSF activity is due to its protein and heat-stable components. The Namalwa IPSF stimulated proliferation of human-to-human hybridomas but not that of mouse-to-mouse hybridomas. The IPSF also stimulated Ig production of human-to-human hybridomas derived from NAT-30 cells, but not that of other human-to-human or mouse-to-mouse hybridomas. NAT-30 is a human fusion partner derived from Namalwa cells. These results suggest that the Namalwa IPSF is an autocrine factor that stimulates proliferation and Ig production of hybridomas derived from NAT-30 cells.

UI MeSH Term Description Entries
D007075 Immunoglobulin M A class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally was called a macroglobulin. Gamma Globulin, 19S,IgM,IgM Antibody,IgM1,IgM2,19S Gamma Globulin,Antibody, IgM
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D002051 Burkitt Lymphoma A form of undifferentiated malignant LYMPHOMA usually found in central Africa, but also reported in other parts of the world. It is commonly manifested as a large osteolytic lesion in the jaw or as an abdominal mass. B-cell antigens are expressed on the immature cells that make up the tumor in virtually all cases of Burkitt lymphoma. The Epstein-Barr virus (HERPESVIRUS 4, HUMAN) has been isolated from Burkitt lymphoma cases in Africa and it is implicated as the causative agent in these cases; however, most non-African cases are EBV-negative. African Lymphoma,Burkitt Cell Leukemia,Burkitt Tumor,Lymphoma, Burkitt,Burkitt Leukemia,Burkitt's Leukemia,Burkitt's Lymphoma,Burkitt's Tumor,Leukemia, Lymphoblastic, Burkitt-Type,Leukemia, Lymphocytic, L3,Lymphocytic Leukemia, L3,Burkitts Leukemia,Burkitts Lymphoma,Burkitts Tumor,L3 Lymphocytic Leukemia,L3 Lymphocytic Leukemias,Leukemia, Burkitt,Leukemia, Burkitt Cell,Leukemia, Burkitt's,Leukemia, L3 Lymphocytic,Lymphoma, African,Lymphoma, Burkitt's,Tumor, Burkitt,Tumor, Burkitt's
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002845 Chromatography Techniques used to separate mixtures of substances based on differences in the relative affinities of the substances for mobile and stationary phases. A mobile phase (fluid or gas) passes through a column containing a stationary phase of porous solid or liquid coated on a solid support. Usage is both analytical for small amounts and preparative for bulk amounts. Chromatographies
D006133 Growth Substances Signal molecules that are involved in the control of cell growth and differentiation. Mitogens, Endogenous,Endogenous Mitogens
D006358 Hot Temperature Presence of warmth or heat or a temperature notably higher than an accustomed norm. Heat,Hot Temperatures,Temperature, Hot,Temperatures, Hot
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006825 Hybridomas Cells artificially created by fusion of activated lymphocytes with neoplastic cells. The resulting hybrid cells are cloned and produce pure MONOCLONAL ANTIBODIES or T-cell products, identical to those produced by the immunologically competent parent cell. Hybridoma

Related Publications

K Yamada, and K Akiyoshi, and H Murakami, and T Sugahara, and I Ikeda, and K Toyoda, and H Omura
Purification and characterization of immunoglobulin production stimulating factor-II beta derived from Namalwa cells.
January 1992, Cytotechnology,
K Yamada, and K Akiyoshi, and H Murakami, and T Sugahara, and I Ikeda, and K Toyoda, and H Omura
Purification of immunoglobulin production stimulation factor II alpha derived from Namalwa cells.
March 1991, Cytotechnology,
K Yamada, and K Akiyoshi, and H Murakami, and T Sugahara, and I Ikeda, and K Toyoda, and H Omura
Purification and characterization of immunoglobulin production stimulating factor derived from human B lymphoblastoid HO-323 cells.
March 1990, Cytotechnology,
K Yamada, and K Akiyoshi, and H Murakami, and T Sugahara, and I Ikeda, and K Toyoda, and H Omura
Characterization and partial purification of a macrophage-stimulating factor from Mycoplasma hominis.
December 2005, American journal of reproductive immunology (New York, N.Y. : 1989),
K Yamada, and K Akiyoshi, and H Murakami, and T Sugahara, and I Ikeda, and K Toyoda, and H Omura
Immunoglobulin production stimulating and inhibiting factors derived from human lung adenocarcinoma PC-8 cells : Ig production stimulating factor in PC-8 cells.
November 1988, Cytotechnology,
K Yamada, and K Akiyoshi, and H Murakami, and T Sugahara, and I Ikeda, and K Toyoda, and H Omura
Purification and partial characterization of recombinant human differentiation-stimulating factor.
September 1990, Protein expression and purification,
K Yamada, and K Akiyoshi, and H Murakami, and T Sugahara, and I Ikeda, and K Toyoda, and H Omura
Platelet-derived growth factor: purification and partial characterization.
August 1979, Proceedings of the National Academy of Sciences of the United States of America,
K Yamada, and K Akiyoshi, and H Murakami, and T Sugahara, and I Ikeda, and K Toyoda, and H Omura
Purification and partial characterization of a megakaryocyte colony-stimulating factor from human plasma.
April 1985, The Journal of clinical investigation,
K Yamada, and K Akiyoshi, and H Murakami, and T Sugahara, and I Ikeda, and K Toyoda, and H Omura
A platelet factor stimulating the proliferation of vascular endothelial cells. Partial purification and characterization.
August 1985, Experimental cell research,
K Yamada, and K Akiyoshi, and H Murakami, and T Sugahara, and I Ikeda, and K Toyoda, and H Omura
Purification and partial characterization of prostate-derived growth factor.
November 1986, Proceedings of the National Academy of Sciences of the United States of America,
Copied contents to your clipboard!